Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconTERNTerns Pharmaceuticals$6.11bnn/an/a
us flag iconSRRKScholar Rock Holding$5.72bnn/an/a
us flag iconCGONCG Oncology$5.70bnn/an/a
us flag iconBLTEBelite Bio$5.67bnn/an/a
us flag iconMTSRMetsera$5.58bnn/an/a
us flag iconCOGTCogent Biosciences$5.57bnn/an/a
us flag iconISEEIVERIC bio$5.51bnn/an/a
us flag iconXENEXenon Pharmaceuticals$5.26bnn/an/a
us flag iconLEGNLegend Biotech$5.17bnn/an/a
us flag iconAPGEApogee Therapeutics$5.10bnn/an/a
us flag iconDNTHDianthus Therapeutics$4.90bnn/an/a
us flag iconCRSPCrispr Therapeutics AG$4.81bnn/an/a
us flag iconFOLDAmicus Therapeutics$4.55bnn/an/a
us flag iconAKROAkero Therapeutics$4.49bnn/an/a
us flag iconSYNHSyneos Health$4.46bn28.55n/a
us flag iconALPNAlpine Immune Sciences$4.46bnn/an/a
us flag iconNAMSNewAmsterdam Pharma NV$4.18bnn/an/a
us flag iconMRTXMirati Therapeutics$4.12bnn/an/a
us flag iconALKSVAlkermes$4.05bn18.02n/a
us flag iconBLLNBillionToOne$3.96bn122.66n/a